Prediction Market for Clinical Trials

Current Trials

Choroidal Melanoma; Indeterminate Lesions; Uveal Melanoma; Ocular Melanoma disease context

A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy

The primary objective is to determine the safety and efficacy of belzupacap sarotalocan (bel-sar) compared to sham control in patients with primary indeterminate...

Mar 30EnrollmentPhase 3

Yes

50%

Trial	Company	Yes	No	Catalyst
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy The primary objective is to determine the safety and efficacy of belzupacap sarotalocan (bel-sar) compared to sham control in patients with primary indeterminate...	Aura Biosciences	50%	50%	Mar 30EnrollmentPhase 3

The prediction market for clinical trials.

Current Trials

The prediction market
for clinical trials.